INFLUENCE OF VORTIOXETINE AND PIOGLITAZONE ON NEUROPHYSIOLOGICAL MANIFESTATIONS IN A RAT MODEL OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY

Authors:

Abstract:

The purpose of the study was to evaluate the effects of vortioxetine and pioglitazone on the neurophysiological manifestations of chemotherapy-induced peripheral neuropathy in rats induced by paclitaxel, cisplatin, or their combination. The study investigated the neurophysiological manifestations of peripheral neuropathy induced by paclitaxel, cisplatin, or their combination, and evaluated the efficacy of vortioxetine (5 mg/kg) and pioglitazone (20 mg/kg) in their correction in a rat model. Von Frey (mechanical allodynia), hot plate (thermal hyperalgesia), and Rotarod (motor impairment) tests were conducted in 12 groups of animals (n=30) over 120 days. Chemotherapy induced an expressed allodynia and hyperalgesia, peaking at day 7. Prophylactic and therapeutic administration of vortioxetine and pioglitazone significantly reduced these manifestations by days 14–28. Motor impairments remained unaffected. The results suggest the potential of vortioxetine and pioglitazone for neuropathy correction.

Keywords:

peripheral neuropathy paclitaxel cisplatin vortioxetine pioglitazone mechanical allodynia thermal hyperalgesia rats

References:

1. Adamo D, Calabria E, Coppola N, Pecoraro G, Mignogna MD. Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update. Ther Adv Psychopharmacol. 2021; 11: 1-19. doi:10.1177/20451253211034320.
2. Aldendail CF, Chen P, Dibble HS, Penry VB. A Comprehensive Review of Safety, Efficacy, and Indications for the Use of Alpha-Lipoic Acid and Acetyl-L-Carnitine in Neuropathic Pain. Integr Med (Encinitas). 2024; 23(3): 32-39.
3. Benvenutti L, Wolff FR, Corrêa TP, Melato J, Goldoni FC, De Faveri R. et al. A partial agonist of PPARγ prevents paclitaxel-induced peripheral neuropathy in mice, by inhibiting neuroinflammation. Br J Pharmacol. 2024; 181(7): 1128–1149. doi:10.1111/bph.16244.
4. Burgess J, Ferdousi M, Gosal D, Boon C, Matsumoto K, Marshall A. et al. Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Oncol Ther. 2021; 9(2): 385–450. doi: 10.1007/s40487-021-00168-y/tables/6.
5. Fumagalli G, Monza L, Cavaletti G, Rigolio R, Meregalli C. Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy. Front Immunol. 2021; 11: 626687. doi:10.3389/fimmu.2020.626687.
6. Ghosh A, Shukla S, Dhankar M, Naik SS, Subodh BN, Basu D. Understanding pregabalin misuse and dependence: Insights from a North Indian addiction treatment center. Indian J Psychiatry. 2024; 66(8): 723–728. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_307_24.
7. Khasabova IA, Khasabov SG, Olson JK, Uhelski ML, Kim AH, Albino-Ramírez AM, et al. Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress. Pain. 2019; 160(3): 688–701. doi:10.1097/j.pain.0000000000001448.
8. Ma X, Zhou S, Sun W, Sun J, Li G, Wang Liu et al. Efficacy and safety of duloxetine in chronic musculoskeletal pain: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2023; 24(1): 1–12. doi:10.1186/s12891-023-06488-6/figures/8.
9. Micov AM, Tomić MA, Todorović MB, Vuković MJ, Pecikoza UB, Jasnic NI. et al. Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy. Prog Neuropsychopharmacol Biol Psychiatry. 2020; 103: 109975. doi:10.1016/j.pnpbp.2020.109975.
10. Papagiouvannis G, Theodosis-Nobelos P, Tziona P, Gavalas A, Kourounakis PN, Rekka EA. Gabapentin Antioxidant Derivatives with Anti-Inflammatory and Neuroprotective Potency. Lett Drug Des Discov. 2021; 19(7): 579–590. doi:10.2174/1570180818666211210161922/cite/refworks.
11. Suzuki K, Morishita S, Nakano J, Okayama T, Inoue J, Tanaka T. et al. Neurological Outcomes of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer: A Systematic Review and Meta-Analysis. Integr Cancer Ther. 2023; 22: 15347354231185110. doi: 10.1177/15347354231185110.
12. Tykhonovych KV, Neporada KS, Yeroshenko GA. Pathomorphological changes in salivary glands of rats under the condition of diabetic neuropathy and correction. World of medicine and biology. 2023;19(83):229. doi: 10.26724/2079-8334-2023-1-83-229-232.
13. Vastyanov RS, Stoyanov OM, Babienko VV, Hruzevskiy OA, Talalayev KO, Kirchev VV. et al. Plasma rich platelets anti-inflammatory effect in conditions of carrageenan-induced paw edema in rats. World of Medicine and Biology. 2024; 4(90): 170-175. doi 10.26724/2079-8334-2024-4-90-170-175.
14. Vitoria Da Lobo M, Hardowar L, Valentine T, Tomblin L, Guest C, Sharma D. et al. Early-life cisplatin exposure induces neuroinflammation and chemotherapy-induced neuropathic pain. Dis Model Mech. 2024; 17(11): dmm052062. doi: 10.1242/dmm.052062.
15. Xu Y, Jiang Z, Chen X. Mechanisms underlying paclitaxel-induced neuropathic pain: Channels, inflammation and immune regulations. Eur J Pharmacol. 2022; 933:175288. doi:10.1016/j.ejphar.2022.175288.

Publication:

«World of Medicine and Biology» Vol. 21 No. 93 (2025) , с. 177-181
УДК 615.277.3.099.616.8

DOI:

https://doi.org/10.26724/2079-8334-2025-3-93-177-181